Morosini Deborah Insider Trades

Insider Trading History

Track insider trading activity for Morosini Deborah. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $367k 90,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$952k 90,000 shares
$10.58
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $796k 195,163 shares
Last Trade
Dec 15, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$382k 28,751 shares
$13.30
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $119k 29,195 shares
Last Trade
Dec 15, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$382k 28,751 shares
$13.30
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $1.81k 444 shares
Last Trade
Dec 15, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$374k 28,751 shares
$13.00
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $3.44k 844 shares
Last Trade
Nov 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$457k 28,751 shares
$15.88
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $119k 29,195 shares
Last Trade
Nov 16, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$461k 28,751 shares
$16.02
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $800k 196,045 shares
Last Trade
Nov 16, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$461k 28,751 shares
$16.02
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $347k 85,000 shares
Last Trade
Jul 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.65M 85,000 shares
$31.23
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $1.81k 444 shares
Last Trade
Apr 29, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$130k 3,223 shares
$40.29
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $15k 3,667 shares
Last Trade
Apr 29, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$130k 3,223 shares
$40.46
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $17.6k 4,323 shares
Last Trade
Apr 29, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$130k 3,223 shares
$40.46
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $30.8k 7,546 shares
Last Trade
Apr 08, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.74k 100 shares
$37.39
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $2.22k 544 shares
Last Trade
Apr 08, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.74k 100 shares
$37.39
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $1.81k 444 shares
Last Trade
Apr 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$4k 100 shares
$40.00
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $31.2k 7,646 shares
Last Trade
Apr 07, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$39.3k 1,000 shares
$39.25
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $5.89k 1,444 shares
Last Trade
Apr 07, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$39.3k 1,000 shares
$39.25
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $1.81k 444 shares
Last Trade
Apr 07, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$40k 1,000 shares
$40.04
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $1.81k 444 shares
Last Trade
Sep 29, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.8k 444 shares
$28.84
$4.08
Prelude Therapeutics
Prelude Therapeutics PRLD
Evp, Chief Of Clinical Affairs
Holding Value $0 0 shares
Last Trade
Sep 24, 2020 Sale
No data
No data
$4.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up